Mary Dixon
CEO/President
Ms. Dixon brings over 25 years experience in the clinical research industry where she has managed successful cross-functional research teams and implemented development plans for multiple compounds, historically contributing to the development of 14 marketed compounds. Mary has experience working for both large and small pharma companies and managing contract research organizations.
Most recently, she has lead disruptive innovative teams at pharmaceutical companies, inspiring them to go “Beyond Therapeutics” in their research initiatives.
In addition to her contributions to drug development, she currently leads biomarker identification and development teams and facilitates cross-functional, cross-divisional collaborations to develop medical devices, including decision support software that serve patients with rare diseases.
